Events

A practical look at overcoming viscosity, fouling, and aggregation with modern TFF platforms. As monoclonal antibody therapies continue to evolve, the industry is rapidly shifting from traditional mAb formulations to high‑concentration mAbs to enable subcutaneous delivery, improve patient convenience, and support next‑generation therapeutics. While this shift delivers clear clinical benefits, it also introduces new risks...

Selective gene delivery to defined cell populations using targeted lentiviral vectors (LVV) represents a promising strategy for next‑generation immunotherapies such as chimeric antigen receptor (CAR) T‑cell therapy. While conventional CAR-T cell manufacturing requires multiple ex vivo manipulation steps up to two weeks, targeted LVVs can enable a short ex vivo manufacturing process or direct in...

Microphysiological (MPS) systems are proving to be increasingly valuable for early drug discovery. By recreating human‑specific physiology—fluid flow, barrier function, multicellular interactions, and organ‑level mechanics—organ‑on‑chip models generate insight that’s difficult to obtain from traditional cell lines or animals. They support target validation research and they enable early efficacy modeling for processes like neuroinflammation, fibrosis, barrier...

Explore why regional supply chain diversification and strong CDMO partnerships are no longer optional, but essential for resilience, speed, and compliance in 2026. Hear directly from top industry experts and CDMO leaders as they share actionable strategies, real-world insights, and urgent steps companies must take to secure capacity, reduce risk, and stay competitive.

In bio-process control, including mammalian cell cultures as well as microbial fermentation, Cedex Analyzers from Roche CustomBiotech enable fast and reliable determination of the relevant media components, for optimization of the protocols and for monitoring of routine processes to achieve optimal yield and product quality. More than 30 parameters can be analyzed on the same...

Join us for a virtual expo built for clinical teams that need to evaluate Interactive Response Technology / Randomization & Trial Supply Management platforms. Selecting the right supplier is a vital decision that impacts patient safety, data integrity, and site compliance. The Clinical Leader Solutions Expo is designed to support clinical research experts in accelerating...

Discover how integrated in silico and in vitro approaches can assess developability, manufacturability, and immunosafety at the earliest stages. Learn how a toolbox strategy enables smarter candidate selection, reduces downstream risk, and supports faster progression of multi-specific antibodies into clinical development. Key takeaways include: - Early identification of developability and immunosafety risks in multi-specific antibodies...

Explore how data-driven tools and Process Analytical Technology (PAT) can optimize scale-up, enhance process control, and reduce risk from cell culture through drug product. Learn how integrating advanced modeling and real-time monitoring enables more reliable, cost-effective, and scalable biologics production. Key takeaways include: - Applying predictive, engineering-driven models to improve bioreactor scale-up and performance -...

Downstream process development is rapidly evolving as new modalities, from mAbs to mRNA, viral vectors, and other complex molecules, enter development pipelines. This webinar will share practical strategies and analytical considerations for designing robust, scalable purification processes across diverse molecule types. Drawing on decades of chromatography innovation and the expertise of our global Fast Trak™...

AI is making it possible to simulate clinical trials before they begin using realistic synthetic patient cohorts built from real-world data. In this session, you’ll see how these simulations compare to actual Phase 2 and Phase 3 trial data, and how teams are using them to test protocols, reduce risk, and improve study design faster....

The informed consent process is an ongoing dialogue that helps participants decide, with full understanding, whether to take part in a clinical trial. As generative AI begins to influence how consent documents are created, translated, and delivered, this process is becoming more complex. Join experts in IRB oversight, research ethics, and health literacy to explore...

We are very excited to announce our outdoor Biotech Community Event at the Biovista Life Science Campus. Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. ✨ What to Expect: Vendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge...